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SUMMARY
Aim: To report a case of successful treatment of a classic subfoveal
choroidal neovascularization with a transpupillary
thermotherapy protocol.
Case Report: A 67-year old pensioner presented with a six-
month history of reduced vision in both eyes. He had been
previously diagnosed with primary open angle glaucoma.
After anterior and posterior segment examination and
fundus fluorescein angiography were done, a diagnosis of a
classic subfoveal choroidal neovascularization secondary to
exudative age-related macular degeneration OS with bilateral
cataracts and primary open angle glaucoma OU was made.
Complete resolution of the choroidal neovascular
membrane was achieved with transpupillary thermotherapy.
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INTRODUCTION
Transpupillary thermotherapy (TTT) is a low irradiance, large
spot size, prolonged exposure (long pulse), infrared laser
photocoagulation protocol  which is presently being1
investigated for use in the treatment of choroidal neovascular
membranes.
Its main advantages are that the infrared lasers are
absorbed less by xanthophyll pigments and thus damage to
the nerve fibre layer is minimized. Compared to the argon
laser, the infrared diode is also poorly absorbed by
haemoglobin, allowing an improved ability to treat through
preretinal and subretinal haemorrhage.2
The relatively larger spot size of the laser beam also
enables treatment of larger lesions with a single burn. TTT has
only been recently put to use at The Eye Foundation, Ikeja,
Lagos. The case being reported here is one of a patient
diagnosed with a classic subfoveal choroidal
neovascularization that was treated with TTT.
CASE REPORT
Mr J AO, a 67-year-old pensioner, presented to our hospital on
the 9  of December 2004 with a complaint of reduced vision inth
both eyes, over a period of 6 months. He wears glasses and
had earlier been diagnosed with chronic primary open angle
glaucoma. He had been on treatment for systemic
hypertension for eight years and had had bilateral
trabeculectomies in May 2002.
Examination on presentation revealed visual acuities of
hand movements OD and counting fingers at 2 metres OS.
Pupillary light reactions and extraocular muscle movements
were normal in both eyes. Both conjunctivae showed cystic
filtering blebs with intraocular pressures of 12mmHg OD and
16 mmHg OS by applanation tonometry. Gonioscopy revealed
open angles of Shaffer grade 3-4 in both eyes. There were
definite posterior subcapsular cataracts in both eyes but worse
in the right.
A fundus examination revealed bilateral intermediate and
large macular drusen, with macular subretinal haemorrhages
OS and cup to disc ratio of 0.8 in both eyes.
The patient was assessed to have:
1. Bilateral age-related macular degeneration, exudative OS
2. Bilateral posterior subcapsular cataracts worse OD
3. Bilateral primary open angle glaucoma
He underwent a fundus flourescein angiography on the
16  of December 2004 which revealed a classic subfovealth
choroidal neovascularization in the left eye ( figures 1a and 1b)
the right eye had no choroidal neovascular lesion.
Subsequently, he had TTT laser treatment of his left eye
on the same day the angiography was done. Parameters used
were spot size 3.00 mm , power setting 500mW and duration
60s. He also had a right extracapsular cataract extraction with
a posterior chamber implant on the 25  of January, 2005.th




During his clinic visit on the 25  of May 2005, visualth
acuities were counting fingers OD and 6/60 OS. These
improved with refraction thus: 
OD! 0.50 DS/!4.00 dcyl* 10 =6/36
OS+ 0.50 DS/!1.50 dcyl*80= 6/36
Add +3.00OS=N 36
Anterior segment findings were normal with the
exception of the right pseudophakia and posterior subcapsular
cataracts in the left eye. Both discs were pale and cupped with
cup to disc ratio of 0.8 and normal intraocular pressures.
Figure 2 shows a complete resolution of the subfoveal
lesion at 2 months after treatment, with his glaucoma control.
At last visit he was taking G Betoptic 0.5 % 12 hourly OU and
one antioxidant tablet twice daily. He felt much better and




Subfoveal choroidal neovascularization still remains a
management challenge to ophthalmologists. Medicare
guidelines in the United States of America presently favour
photodynamic therapy (PDT) for predominately classic
subfoveal neovascularization.  However, in our environment,3
this treatment modality is very expensive; each vial of
visodyne costs E850.00, which is approximately N=212, 500.00.
This excludes the cost of fundus fluorescein angiography and
the surgeon’s fees. It should also be noted that repeated
treatment sessions are often needed for PDT and that not all
subfoveal neovascular lesions respond well to this treatment
modality.
The advent of multiple research into the use of TTT in the
management of these lesions is, therefore, of great interest.
TTT has been evaluated for use in both occult and classic
choroidal neovascularization and encouraging results have
been reported.4, 5, 6
In our hospital TTT is done with the IRIS medical;
oculight SLX infrared (810nm) solid state laser with tri-mode,
using a slit lamp delivery method and a Goldman’s 3 mirror
lens. Our preferred parameters of 60 seconds duration, 3mm
spot size and power settings are usually varied depending on
the location and size of the lesion and the patients pain
threshold.
TTT in our patient achieved a complete resolution of the
choroidal neovascular membrane without adversely affecting
his intraocular pressures. 
This case report adds a positive word for the ongoing
clinical trials on the uses of TTT for choroidal neovascular
membranes.
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